⭐ Recognized by FeedSpot: #12 Best Anesthesiology Blog Worldwide

Uncategorized Published - 6 January, 2016    By - Dr Clemens
Inadvertent Hypothermia After Procedural Sedation and Analgesia in a Cardiac Catheterization Laboratory: A Prospective Observational Study

J Cardiothorac Vasc Anesth 2015 Oct;29(5):1285-90. Authors: Conway A et al OBJECTIVES: To identify the prevalence of and risk factors for inadvertent hypothermia after procedures performed with procedural sedation and analgesia in a cardiac catheterization laboratory. DESIGN: A single-center, prospective observational study. SETTING: A tertiary-care private hospital in Australia. PARTICIPANTS: 399 patients undergoing elective procedures with procedural […]

Read More
Uncategorized Published - 6 January, 2016    By - Dr Clemens
Greater Use of Opioids During Cancer Treatment Can Reduce Survival

High opioid exposure is a prognostic factor for shorter overall survival, according to a study presented here at the 2015 American Society of Clinical Oncology (ASCO) Palliative Care in Oncology Symposium. The study involved patients with stage IV non-hematologic malignancies. For these and other patients with advanced cancer, pain is a challenging problem. “Opioids are […]

Read More
Uncategorized Published - 6 January, 2016    By - Dr Clemens
Comparison of intra-articular bupivacaine-morphine with bupivacaine-tenoxicam combinations on post-operative analgesia in patients with arthroscopic meniscectomy: a prospective, randomised study

Int Orthop 2015 Sep 15. Authors: Sanel S et al AIM: There are many alternatives for post-operative pain relief in patients who have had general anaesthesia. The aim of this study was to evaluate the efficacy of intra-articular bupivacaine + morphine and bupivacaine + tenoxicam applications in post-operative pain control in patients undergoing knee arthroscopy with general […]

Read More
Uncategorized Published - 6 January, 2016    By - Dr Clemens
Long-term Safety and Efficacy of Tapentadol Extended Release Following up to 2 Years of Treatment in Patients With Moderate to Severe, Chronic Pain: Results of an Open-label Extension Trial

Clin Ther 2015 Nov 1;37(11):2420-38. Authors: Buynak R et al PURPOSE: Tapentadol extended release (ER) has demonstrated efficacy and safety for the management of moderate to severe, chronic pain in adults. This study evaluated the long-term safety and tolerability of tapentadol ER in patients with chronic osteoarthritis or low back pain. METHODS: Patients were enrolled in this […]

Read More
Uncategorized Published - 6 January, 2016    By - Dr Clemens
Over 90% of Opioid Overdose Survivors Continue to Be Prescribed Opioids

Most patients who experience a nonfatal prescription opioid overdose continue to receive opioids afterward, increasing their risk for a second overdose, finds a retrospective study in the Annals of Internal Medicine. Using data from a U.S. health insurer, researchers studied some 2800 adults who survived a first opioid overdose during long-term opioid therapy for noncancer pain. […]

Read More